The research, funded by the British Heart Foundation and published in the journal Circulation, opens the prospect of treating the condition at the earliest stages.
Hong Kong approves Leqembi for Alzheimer’s treatment
Leqembi is the first treatment proven to slow the progression of AD. Credit: Lighthunter/Shutterstock. Swedish research-based biopharma company BioArctic has announced that its partner Eisai